Despite decades of medical warnings, one in four Medicare patients with dementia continues receiving brain-altering medications that dramatically increase their risk of dangerous falls, hospitalizations, and worsening confusion.

Story Highlights

• 25% of Medicare beneficiaries with dementia still prescribed risky CNS-active drugs despite clinical guidelines warning against their use
• Over two-thirds of 2021 prescriptions lacked documented clinical justification, representing millions of potentially inappropriate treatments
• While overall prescribing declined from 20% to 16% among all Medicare patients, dementia patients remain disproportionately targeted
• Antipsychotic prescriptions actually increased during the study period, even as benzodiazepine use dropped significantly

The Vulnerable Population Under Attack

A UCLA-led study published in JAMA reveals a disturbing pattern of medical negligence affecting millions of America’s most vulnerable citizens. Medicare beneficiaries with dementia receive these dangerous medications at rates 47% higher than those with normal cognition, despite having the greatest risk for adverse effects. The drugs in question—benzodiazepines, antipsychotics, barbiturates, and anticholinergic antidepressants—directly interfere with brain chemistry already compromised by dementia.

These medications manipulate critical neurotransmitters including dopamine, serotonin, GABA, and acetylcholine. In dementia patients, this chemical interference creates a perfect storm of complications: delirium, severe gait instability, increased fall risk, and accelerated cognitive decline. The human cost extends far beyond statistics—families watch loved ones deteriorate faster while medical professionals continue prescribing the very drugs causing harm.

Watch:

Nine Years of Documented Failure

The research team analyzed Medicare fee-for-service claims from 2013 to 2021, tracking prescription patterns across different cognitive groups. Their findings expose a medical system that pays lip service to safety guidelines while continuing harmful practices. Although overall prescribing rates dropped modestly from 20% to 16%, the improvement masks a troubling reality: dementia patients remained trapped at consistently high prescription rates.

The data reveals selective progress that raises questions about priorities. Benzodiazepine prescribing fell from 11.4% to 9.1%, and sleep medication use plummeted from 7.4% to 2.9%. Yet antipsychotic prescriptions increased from 2.6% to 3.6%, suggesting physicians simply shifted from one dangerous drug class to another rather than addressing root causes of patient distress.

The Documentation Scandal

Perhaps most damning is the revelation that over two-thirds of 2021 prescriptions lacked documented clinical justification. This represents a massive failure of medical accountability. Dr. John Mafi, the study’s senior author and UCLA associate professor of medicine, characterized this as evidence of “substantial opportunities to improve care”—a diplomatic way of describing what amounts to systematic medical negligence.

The absence of documentation suggests physicians either cannot justify their prescribing decisions or simply refuse to document them properly. Both scenarios represent serious breaches of medical standards. When dealing with patients whose cognitive impairment makes them unable to advocate for themselves, this lack of accountability becomes particularly egregious. These are not isolated incidents but patterns affecting millions of vulnerable Americans.

The Path Forward Requires Courage

Dr. Annie Yang, the study’s lead author, advocates for patients and physicians to “work closely together” on tapering strategies and alternatives. However, this collaborative approach assumes a level of medical engagement that the documentation failures suggest may be lacking. The solution requires more than gentle encouragement—it demands systemic accountability and enforcement of existing guidelines.

While some progress occurred in specific drug categories, the persistence of unjustified prescribing after years of clear warnings suggests many physicians either ignore established guidelines or lack the commitment to implement safer care practices. American families deserve better than a medical system that continues harming their most vulnerable members.

Your instant doctor companion – online 24 hours a day.

Sources:

ScienceDaily – Millions with dementia still prescribed drugs linked to falls and confusion
UCLA Newsroom – Older Americans with dementia prescribed risky brain-altering drugs
Powers Health – Seniors with dementia being prescribed dangerous mind-altering drugs
UCLA Health – One in four older Americans with dementia prescribed risky drugs
MDLinx – New study finds 1 in 4 dementia patients receive high-risk drugs
McKnight’s – One in four older Americans with dementia prescribed high-risk CNS meds
SciTechDaily – Warning: These common dementia drugs can increase confusion and hospitalization